COGNICURRENT

A safety alert has been issued regarding counterfeit Mounjaro pens, urging users to check batch numbers following a recall of certain products.

The article discusses various weight loss strategies, emphasizing that effective weight loss requires burning more calories than consumed, alongside the role of the brain and hormones in weight regulation.

Authorities in Maceió, Brazil, have shut down an illegal factory producing counterfeit weight loss pens and arrested a suspect with a criminal history.

Brazilian pharmaceutical firms Biomm and Amoveri are pursuing Indian technology agreements to produce weight loss pens ahead of the patent expiration for Ozempic in 2026.

Emma Dyer, a British woman, warns about the dangers of purchasing weight-loss pens online without proper medical supervision.

Brazil's pharmaceutical retail sector generated approximately R$ 128.6 billion in 2025, bolstered by the popularity of weight-loss pens like Mounjaro, Ozempic, and Wegovy.

Recent findings raise concerns among doctors regarding weight-loss medications that may cause excessive weight loss.

A man was arrested in Gama, Federal District, Brazil, for possessing irregular weight-loss pens following a police operation prompted by health surveillance authorities.

A couple was caught on security cameras stealing weight loss pens from a pharmacy in Franca, SP, after holding the employees at gunpoint with a stun gun.

The Federal Highway Police (PRF) intercepted a truck carrying weight-loss pens, cell phones, appliances, and a video game in Piauí, revealing issues with legal compliance regarding purchases made in Paraguay.

Anvisa has reported 65 notifications of suspected deaths related to the use of weight loss medications known as pens between December 1, 2018, and December 7, 2025.

Brazil's health regulatory agency, Anvisa, reports 65 suspected deaths linked to the use of weight loss pens from December 2018 to December 2025, with a significant increase in reported adverse events.

McDonald's is observing the rising trend of weight loss medications, particularly GLP-1 injections, and their potential impact on consumer behavior before considering menu alterations in the United States.

More women are increasingly using GLP-1 receptor agonist medications known as 'slimming pens' in the postpartum period, according to a recent study.

Two individuals were arrested in Pouso Alegre, Brazil, for smuggling and fraud involving unauthorized medications including weight loss pens and in vitro fertilization drugs.

The article covers various topics including the recent Carnaval results in Rio, illegal sales of weight loss pens, and political updates.

Brazilian pharmacies and laboratories are illegally selling unapproved weight-loss injections despite regulations from health authorities.

US restaurants are downsizing their portion sizes and introducing lighter menus as a response to rising costs and the increased use of weight loss medications like Ozempic.

The article discusses the rise of GLP-1 medications for weight loss, highlighting their effectiveness and increased accessibility with the introduction of oral formulations.

Brazil's National Health Surveillance Agency (Anvisa) is expected to announce its decision regarding the registration of national versions of semaglutide-based pens, essential for diabetes treatment, next week.

A farmer was attacked by a cow in Stjørdal while moving calves and cattle between pens.

Weight loss pens, specifically GLP-1 agonists like Ozempic and Mounjaro, are projected to represent 20% of the revenue of major pharmacy chains in Brazil by 2030.

Brazilians are allocating less of their budgets to essential fast-moving consumer goods due to the rise of non-traditional expenditures like weight loss pens and betting services.

Brazil's health agency warns about the risks of using weight loss pens without medical supervision, highlighting potential severe side effects.

A young public relations professional experienced health issues while celebrating a pre-Carnival event in São Paulo, highlighting concerns over the risks of mixing weight-loss medications with alcohol.

Brazilian delivery platform Shopper has launched a new category for customers using weight loss pens, featuring premium food products specifically catered to their dietary needs.

Brazil's Vice President Geraldo Alckmin expressed opposition to a legislative bill aimed at breaking patents for weight loss pens, Mounjaro and Zepbound, arguing it would deter investment and innovation.

The Federal Police in Brazil seized 152 'weight loss pens' alongside other contraband items from a suspect in Maceió.

Illegal sales of weight-loss pens over social media platforms in Ceará have raised health concerns due to unregulated distribution.

Izadora Morais, the muse of Colorado do Brás, has withdrawn from the São Paulo carnival following health complications from using weight loss pens.

A couple arrested for selling smuggled weight loss pens was released on provisional bail after a court hearing in Brazil.

Four cases of neurological side effects following the use of weight loss pens have been reported in Santa Catarina, Brazil, linked to the substance tirzepatide in the injectable medication Mounjaro.

A couple was arrested in Pindamonhangaba, Brazil, for allegedly selling smuggled weight loss pens known as Tirzepatida.

A Brazilian medical student studying in Paraguay and his grandmother were caught with 462 illegal weight-loss pens during a routine inspection in Paraná en route to São Paulo.

Brazil's health regulatory agency Anvisa has issued a warning about the risks associated with improperly using weight loss pens, including acute pancreatitis, which can be fatal.

Two individuals were arrested for the illegal trade of weight loss pens and medications without proper documentation in Santa Fé do Sul, Brazil.

Brazil's health agency Anvisa has issued a warning regarding the misuse of weight loss pens, highlighting a link to acute pancreatitis.

A driver was arrested in Brazil for illegally transporting 400 vials of tirzepatide, a medication used in weight loss pens, while on his second delivery trip from Medianeira to Guarulhos.

Brazil's health agency issues a warning about the risk of pancreatitis associated with GLP-1 agonist medications, also known as weight loss pens, following reports of suspected deaths.

Multiple serious issues are being reported in Brazil, including a potential link between deaths and weight loss pens, inflation concerns, and a troubling corruption perception index.

Brazil's Federal Police report that Amapá's pension fund opted for Master over top-tier banks despite warnings, amidst a backdrop of 1.6 million child labor cases and concerns over the health risks of weight loss pens.

Paraguay has acknowledged the illegal trade of counterfeit weight loss pens at its border with Brazil, raising health alarms for both nations.

Anvisa has issued a warning about the risks associated with the use of weight-loss pens after an investigation into pancreatitis cases linked to their usage found suspicious fatalities in Brazil.

The article discusses various significant news items, including a warning from Anvisa regarding slimming pens, China's reduction of investment in the US leading to a lower dollar, and other local incidents in Brazil.

Brazil's health regulatory agency, Anvisa, has issued a warning regarding the dangerous use of weight-loss pens, citing potential health risks including severe pancreatitis and death.

ANVISA issues a warning after a rise in pancreatitis notifications related to weight loss pens.

Anvisa has issued a warning following a spike in pancreatitis notifications related to weight loss pens.

ANVISA has issued a warning following an increase in pancreatitis notifications linked to weight loss pens, while Brazil is investigating six deaths associated with the medication.

Anvisa has issued an alert about the risk of pancreatitis linked to the use of weight loss pens, following reports of six deaths associated with GLP-1 receptor antagonists.

Brazil's health agency Anvisa warns against the use of weight loss pens for obesity and diabetes treatment without medical oversight due to rising cases of pancreatitis.